INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 37 filers reported holding INMUNE BIO INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,269 | -25.4% | 4,471 | 0.0% | 0.00% | – |
| Q2 2023 | $40,597 | +33.2% | 4,471 | -5.2% | 0.00% | – |
| Q1 2023 | $30,472 | +156.9% | 4,717 | +152.1% | 0.00% | – |
| Q4 2022 | $11,862 | -1.2% | 1,871 | +0.7% | 0.00% | – |
| Q3 2022 | $12,000 | -25.0% | 1,858 | 0.0% | 0.00% | – |
| Q2 2022 | $16,000 | -46.7% | 1,858 | -47.8% | 0.00% | – |
| Q1 2022 | $30,000 | -21.1% | 3,558 | -5.6% | 0.00% | – |
| Q4 2021 | $38,000 | +8.6% | 3,769 | +109.5% | 0.00% | – |
| Q3 2021 | $35,000 | +16.7% | 1,799 | +5.8% | 0.00% | – |
| Q2 2021 | $30,000 | +50.0% | 1,700 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | -31.0% | 1,700 | 0.0% | 0.00% | – |
| Q4 2020 | $29,000 | +3.6% | 1,700 | -37.0% | 0.00% | – |
| Q3 2020 | $28,000 | +211.1% | 2,700 | +57.6% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 1,713 | +0.8% | 0.00% | – |
| Q1 2020 | $6,000 | -40.0% | 1,700 | -0.2% | 0.00% | – |
| Q4 2019 | $10,000 | 0.0% | 1,703 | +0.2% | 0.00% | – |
| Q3 2019 | $10,000 | +25.0% | 1,700 | +112.0% | 0.00% | – |
| Q2 2019 | $8,000 | – | 802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 230,500 | $2,351,000 | 1.70% |
| Fermata Advisors, LLC | 17,955 | $183,000 | 0.07% |
| Virtu Financial LLC | 24,364 | $249,000 | 0.02% |
| YorkBridge Wealth Partners, LLC | 10,369 | $106,000 | 0.02% |
| Jump Financial, LLC | 21,100 | $215,000 | 0.01% |
| Financial Advocates Investment Management | 15,167 | $155,000 | 0.01% |
| FNY Investment Advisers, LLC | 1,100 | $11,000 | 0.01% |
| Janney Montgomery Scott LLC | 113,914 | $1,162,000 | 0.01% |
| Walleye Capital LLC | 17,127 | $175,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 12,473 | $127,000 | 0.00% |